148672-74-6Relevant articles and documents
Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors
Lombart, Henry-Georges,Feyfant, Eric,Joseph-McCarthy, Diane,Huang, Adrian,Lovering, Frank,Sun, LinHong,Zhu, Yi,Zeng, Congmei,Zhang, Yuhua,Levin, Jeremy
, p. 4333 - 4337 (2007)
Structure-based methods were used to design β-sulfone 3,3-piperidine hydroxamates as TACE inhibitors with the aim of improving selectivity for TACE versus MMP-13. Several compounds in this series were synthesized and evaluated in enzymatic and cell-based
PYRAZOLOPYRIDAZINE DERIVATIVES, PREPARATION METHOD THEREOF AND COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING THE SAME
-
Paragraph 0245-0249, (2020/11/14)
The present invention is a pyrazolopyridazine derivative. A pharmaceutical composition for preventing or treating cancer contains the pyrazolopyridazin derivative compound Hsp90 according to the present invention as an active ingredient, which can be used as Hsp90 a pharmaceutical composition for preventing or treating Hsp90-related diseases such as melanoma, brain tumor, breast cancer, lung cancer and the like. (by machine translation)
SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF
-
Page/Page column 30; 31, (2018/03/28)
Disclosed are compounds having potency in the modulation of NMDA receptor activity. Such compounds can be used in the treatment of conditions such as depression and related disorders. Orally delivered formulations and other pharmaceutically acceptable delivery forms of the compounds, including intravenous formulations, are also disclosed.